About: 2.6 Anti-infective Agents

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: 2.6 Anti-infective Agents Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	2.6 Anti-infective Agents
Source	Elsevier; PMC
abstract	Abstract Infections may be hazardous to the health of the mother, the course of pregnancy, and the unborn child. They can lead to premature labor or premature rupture of membranes and thereby increase the risk for spontaneous abortion and prematurity. Furthermore, certain germs can pass to the unborn child and harm it directly. Therefore, an anti-infective treatment which should be both effective and safe for the mother and the unborn child is often required. The use of penicillines and older cephalosporines is well documented and considered to be safe. Consequently, they are the drug of choice during pregnancy. In selected cases of bacterial resistance or intolerance to first-line antibiotics, other anti-infective agents might be recommended. Especially for life-threatening infections, a therapy with not so well-tried agents might be needed. The potential benefit of treatment in such cases most often outbalances the potential risk for the unborn child.
has issue date	2015-12-31(xsd:dateTime)
bibo:doi	10.1016/b978-0-12-408078-2.00007-x
has license	els-covid
sha1sum (hex)	d0f3bc94f1c3a34d7704730c3e6fc15a0729b28b
schema:url	https://doi.org/10.1016/b978-0-12-408078-2.00007-x
resource representing a document's title	2.6 Anti-infective Agents
has PubMed Central identifier	PMC7150338
schema:publication	Drugs During Pregnancy and Lactation
resource representing a document's body	covid:d0f3bc94f1c3a34d7704730c3e6fc15a0729b28b#body_text
is schema:about of	named entity 'prenatal' named entity 'mucosa' named entity 'vancomycin-resistant enterococci' named entity 'indinavir' named entity 'malaria prophylaxis' named entity 'pregnancy' named entity 'toxic symptoms' named entity 'didanosine' named entity 'Antiretroviral' named entity 'risk assessment' named entity 'Chloramphenicol' named entity 'elvitegravir' named entity 'ofloxacin' named entity 'Erythromycin' named entity 'halofantrine' named entity 'pregnancy' named entity 'antibiotics' named entity 'placenta' named entity 'pregnancy' named entity 'lipopeptides' named entity 'nevirapine' named entity 'NRTI' named entity 'pregnancy' named entity 'malaria tropica' named entity 'anthelmintic' named entity 'Oxamniquine' named entity 'gentamicin' named entity 'Pregnancy' named entity 'doxycycline' named entity 'pregnancy' named entity 'mycotic' named entity 'lopinavir/ritonavir' named entity 'econazole' named entity 'oxytetracycline' named entity 'teratogenic potential' named entity 'gentamicin' named entity 'INH' named entity 'cardiovascular malformations' named entity 'Rifampicin' named entity 'bactericidal' named entity 'fomivirsen' named entity 'ultrasound' named entity 'follow-up' named entity 'raltegravir' named entity 'pregnancy' named entity 'pregnancy' named entity 'syndactyly' named entity 'observational study' named entity 'endemic areas' named entity 'Anti-infective Agents' named entity 'risk assessment' named entity 'case reports' named entity 'Pyrantel' named entity 'erythromycin' named entity 'erythromycin estolate' named entity 'live births' named entity 'zidovudine' named entity 'Antiretroviral' named entity 'Pseudomembranous enterocolitis' named entity 'fidaxomicin' named entity 'hemolytic anemia' named entity 'antifungal agent' named entity 'macrolide antibiotics' named entity 'DNA synthesis' named entity 'Pregnancy' named entity 'Uganda' named entity 'pregnancy' named entity 'ultrasound' named entity 'Antiretroviral' named entity 'antiretroviral' named entity 'Systematic studies' named entity 'Vancomycin' named entity 'general population' named entity 'nicotinamide' named entity 'rifaximin' named entity 'pregnancy' named entity 'embryo' named entity 'co-trimoxazole' named entity 'artemisinin-based combination therapy' named entity 'didanosine' named entity 'Finland' named entity 'diarrhea' named entity 'tipranavir' named entity 'ribavirin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software